hpp737
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 8, 2020 (NCT04714294)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Phosphodiesterase 4AINHIBITOR
PDE4A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06584058 | N/A | Aug 30, 2024 | Newsoara Biopharma Co., Ltd., Soochow University |
| NCT04714294 | Phase 1 | Sep 8, 2020 | Newsoara Biopharma Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Newsoara Biopharma Co., Ltd. | For profit | 2 | 2 | 2 | 2020 |
| Soochow University | Academic/Hospital | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1